Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of AVAXIM 80U Pediatric Vaccine
NCT00483470Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2007
- Primary completion
- May 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Avaxim Junior in hepatitis A (HAV), sponsored by Sanofi. Started Jun 2007; status: completed.
02
Drugs
Avaxim Junior
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT00483470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00483470.